Company attributes
Venture Capital Firm attributes
Other attributes
Founded in 1993, Three Arch Partners is a venture capital firm based in San Mateo, California. The firm primarily seeks to invest in the healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors.
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 new healthcare companies. These companies have often found success and generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Three Arch Partners' investments include Neuronetics, Ocera Therapeutics, Nevro, Access Closure, iScience International, Inova Labs, Crux Biomedical, Tibion Bionic Technologies, VisionCare Ophthalmic Technologies, TriReme Medical and Respicardia.
Their exited investments include Nevro, Neuronetics, Concert Pharmaceuticals, Threshold Pharmaceuticals, Ocera Therapeutics, Ingenuity Systems, Inova Labs, Cameron Health, Baxano, Access Closure, Free & Clear and Calibra Medical.